🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this registration is to list Managed Access Programs (MAPs) ...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04837703
Treatments Being Tested
This randomized, double-blind and open-label phase III study aimed to deter...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-02-18
Trial ID
NCT01762761
Treatments Being Tested
The MONIRITUX study aimed to evaluate whether monitoring (i) circulating B-...
Status
Recruiting
Location
Chu de Nice
Start Date
2025-06-01
Trial ID
NCT07037732
Immune thrombocytopenic purpura (ITP) is a kind of rare childhood disease t...
Status
Recruiting
Location
Chinese Academy of Medical Science and Blood Disease Hospital
Start Date
2023-11-01
Trial ID
NCT06107582
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
1997-09
Trial ID
NCT00003105
Treatments Being Tested
Chronic immune thrombocytopenic purpura (ITP) is characterized by low plate...
Status
Completed
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT01439321
Treatments Being Tested
Pre-clinical and clinical evaluations show that PRTX- 100 has biological ac...
Status
Terminated
Location
USC Norris Comprehensive Cancer Center
Start Date
2015-09
Trial ID
NCT02401061
Treatments Being Tested
Multicenter retrospective and prospective observational study based on the ...
Status
Unknown
Location
ASST Degli Spedali Civili Di Brescia - UO Ematologia
Start Date
2022-08-22
Trial ID
NCT04735588
Human immunoglobulin (Ig) is the most commonly used blood product. It has b...
Status
Completed
Location
Chungnam National University Hospital
Start Date
2014-06
Trial ID
NCT02063789
Treatments Being Tested
The purpose of this study is to investigate the efficacy, safety of Hetromb...
Status
Completed
Location
Beijing children's hospital .Capital medical university
Start Date
2021-03-29
Trial ID
NCT04737850
Treatments Being Tested